Article
Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
6 Feb 2019
Abstract excerpt
PURPOSE: Severe hematotoxicity in patients with thiopurine therapy has been associated with genetic polymorphisms in the thiopurine S-methyltransferase (TPMT). While TPMT genetic testing is clinically implemented for dose individualization, alterations in the nudix hydrolase 15 (NUDT15) emerged as independent determinant of thiopurine-related hematotoxicity. Because data for European patients are limited, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
